- Investing Ideas
- /
- Commercial Services Healthcare Sector
Commercial Services Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Pheton Holdings
Market Cap: US$93.3m
A healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.
PTHL
US$6.55
7D
18.2%
1Y
n/a
RetinalGenix Technologies
Market Cap: US$93.0m
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders.
RTGN
US$5.02
7D
0%
1Y
n/a
Nautilus Biotechnology
Market Cap: US$92.4m
A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
NAUT
US$0.73
7D
-11.2%
1Y
-72.8%
HilleVax
Market Cap: US$92.3m
A clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.
HLVX
US$1.86
7D
-5.6%
1Y
-85.6%
Contineum Therapeutics
Market Cap: US$92.2m
A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.
CTNM
US$3.57
7D
1.6%
1Y
-77.4%
Monogram Technologies
Market Cap: US$91.8m
Engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States.
MGRM
US$2.60
7D
0.4%
1Y
27.5%
Ironwood Pharmaceuticals
Market Cap: US$91.6m
A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
IRWD
US$0.57
7D
-0.6%
1Y
-90.5%
Cardiol Therapeutics
Market Cap: CA$125.6m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.52
7D
-2.3%
1Y
-52.8%
Corbus Pharmaceuticals Holdings
Market Cap: US$90.6m
A biopharmaceutical company, develops products to defeat serious illness.
CRBP
US$7.40
7D
0.8%
1Y
-83.6%
Elicio Therapeutics
Market Cap: US$90.5m
A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.
ELTX
US$5.66
7D
6.2%
1Y
-32.7%
Invivyd
Market Cap: US$89.8m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$0.75
7D
-3.6%
1Y
-61.2%
Trajan Group Holdings
Market Cap: AU$137.9m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.91
7D
-4.2%
1Y
-7.2%
FONAR
Market Cap: US$89.5m
Engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.
FONR
US$14.13
7D
9.5%
1Y
-7.9%
Cabaletta Bio
Market Cap: US$88.8m
A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.
CABA
US$1.75
7D
-13.8%
1Y
-84.0%
Entera Bio
Market Cap: US$88.6m
A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.
ENTX
US$1.95
7D
-3.9%
1Y
-15.9%
23andMe Holding
Market Cap: US$88.5m
Operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.
MEHC.Q
US$3.30
7D
266.7%
1Y
-67.8%
Fractyl Health
Market Cap: US$88.2m
A metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
GUTS
US$1.80
7D
6.5%
1Y
-75.9%
Immunic
Market Cap: US$87.9m
A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
IMUX
US$0.92
7D
-4.5%
1Y
-26.6%
Coherus BioSciences
Market Cap: US$87.7m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$0.76
7D
-0.6%
1Y
-60.4%
Odysight.ai
Market Cap: US$87.2m
Develops, produces, and markets visualization AI solutions in Israel, the United States, and internationally.
ODYS
US$5.35
7D
-1.5%
1Y
-19.2%
Cibus
Market Cap: US$87.0m
An agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.
CBUS
US$2.53
7D
-10.3%
1Y
-83.7%
Cyclopharm
Market Cap: AU$133.4m
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.
CYC
AU$1.20
7D
0.4%
1Y
-27.3%
Oramed Pharmaceuticals
Market Cap: US$86.6m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$2.12
7D
-1.4%
1Y
-9.4%
XBiotech
Market Cap: US$86.6m
A biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.
XBIT
US$2.84
7D
-6.6%
1Y
-65.8%
Zentalis Pharmaceuticals
Market Cap: US$86.3m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.
ZNTL
US$1.20
7D
-4.8%
1Y
-89.4%
Adagene
Market Cap: US$85.7m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$1.82
7D
2.8%
1Y
-29.5%
Medicus Pharma
Market Cap: US$85.5m
A biotech/life sciences company, focused on accelerating the clinical development programs of novel and disruptive therapeutic assets.
MDCX
US$7.29
7D
8.3%
1Y
n/a
Genetic Signatures
Market Cap: AU$130.6m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.57
7D
-4.2%
1Y
-21.2%
CareCloud
Market Cap: US$84.2m
A healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$1.99
7D
-5.2%
1Y
-21.7%
Arch Biopartners
Market Cap: US$83.7m
Engages in the development of novel drugs for acute kidney injury and organ damage in Canada.
ACHF.F
US$1.27
7D
4.1%
1Y
3.1%
Senti Biosciences
Market Cap: US$83.5m
A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.
SNTI
US$3.20
7D
0.6%
1Y
-5.9%
Imugene
Market Cap: AU$126.9m
A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.
IMU
AU$0.017
7D
-22.7%
1Y
-75.7%
Whitehawk Therapeutics
Market Cap: US$82.3m
An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.
WHWK
US$1.76
7D
2.3%
1Y
-4.3%
Alto Neuroscience
Market Cap: US$82.0m
Operates as a clinical-stage biopharmaceutical company in the United States.
ANRO
US$3.03
7D
19.8%
1Y
-76.5%
Owlet
Market Cap: US$81.8m
Provides digital parenting solutions in the United States, the United Kingdom, and internationally.
OWLT
US$4.95
7D
-6.1%
1Y
35.6%
Auxly Cannabis Group
Market Cap: CA$112.0m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.085
7D
-5.6%
1Y
88.9%